Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Endocrine Mucin-Producing Sweat Gland Carcinoma of Eyelid.

Ophthalmology·2026

Same author

Agency staff utilization in nursing homes: patterns and concerns.

The Gerontologist·2026

Same author

"Getting That Trust Built with Them Helps Make Them Successful": Supporting Older Adults with Substance Use Disorders.

Journal of gerontological social work·2026

Same author

The Prevalence and Impact of Vaccination Programs: Differences Between Nursing Homes and Assisted Living Communities.

Journal of the American Medical Directors Association·2026

Same author

An Assessment of the Association Between Wages and Fringe Benefits on Nurse Aide Turnover in Nursing Homes.

Health services research·2025

Same author

To Opt-In or Opt-Out? The Choice Behind Financial Alignment for Dual-Eligible Beneficiaries in Ohio.

Journal of aging & social policy·2025

Same journal

Porocarcinoma Arising in a Long-Standing Eviscerated Socket.

Ophthalmic plastic and reconstructive surgery·2026

Same journal

Hyper Immunoglobulin E Syndrome With Conjunctival Molluscum Contagiosum.

Ophthalmic plastic and reconstructive surgery·2026

Same journal

Ethmoiditis Mimicking Acute Dacryocystitis-An Underreported Pathology.

Ophthalmic plastic and reconstructive surgery·2026

Same journal

Orbital Inflammatory Syndrome Associated with Bispecific T-Cell Engager Therapy: Case and Literature Review.

Ophthalmic plastic and reconstructive surgery·2026

Same journal

A Rare Pedunculated Lobular Capillary Hemangioma of the Conjunctiva.

Ophthalmic plastic and reconstructive surgery·2026

Same journal

Core Oculoplastic Procedure Skills for the Comprehensive Ophthalmologist: A Consensus by Delphi Methodology.

Ophthalmic plastic and reconstructive surgery·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 9, 2026

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

Operative treatment for segmental eyelid vitiligo.

Arthur M Kahn¹, Robert Applebaum

¹Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA. akahn@ix.netcom.com

Ophthalmic Plastic and Reconstructive Surgery

|August 26, 2010

Summary

This summary is machine-generated.

A novel Erbium YAG laser technique offers a safer, faster method for eyelid vitiligo treatment. This approach enables successful melanocyte transplantation, restoring pigment without scarring.

More Related Videos

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

Related Experiment Videos

Last Updated: Jun 9, 2026

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

Area of Science:

Ophthalmology
Dermatology
Regenerative Medicine

Background:

Segmental eyelid vitiligo presents a cosmetic challenge, often unresponsive to conventional treatments.
Previous surgical approaches for eyelid depigmentation carried risks of scarring and limited efficacy.

Observation:

The Erbium:YAG (Er:YAG) laser facilitated precise epithelial ablation on the nonpigmented eyelid skin.
Subsequent melanocyte-containing epithelial grafts demonstrated excellent viability post-procedure.

Findings:

Successful repigmentation was observed within the first week after grafting.
The Er:YAG laser-assisted procedure resulted in outstanding cosmetic outcomes with no scarring.
The treatment was completed in under 30 minutes under local anesthesia in an outpatient setting.

Implications:

This technique provides a safe and effective therapeutic option for previously untreatable eyelid vitiligo.
The minimally invasive nature and rapid recovery promote patient acceptance and surgical feasibility.
This method expands the surgical armamentarium for managing pigmentary disorders of the eyelid.